Timely Insights for Healthcare Experts 

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Patient-Centered Care & Barriers to Adherence

Patient-Centered Care & Barriers to Adherence

While medical R&D has been making great strides in precision medicine and pharmacogenetics – ultimately tailoring diagnostics and treatments to match individuals on a submolecular level – healthcare providers need to remember that their relationships with their...

read more
What you need to know about Herbal-Drug Interactions

What you need to know about Herbal-Drug Interactions

Evidence that Adverse Drug Interactions Occur from Herbal-Drug Interactions and Non-Prescription Drug Interactions. “Natural” is widely perceived by the public to ensure safety. However, studies show drug interactions with active pharmaceutical agents, and...

read more
Suicide Rates Rising in the United States

Suicide Rates Rising in the United States

U.S. Suicide Rates Rising: Now the 10th Leading Cause of Death Over the past 19 years, U.S. suicide rates have increased in every state except Nevada. Suicide now stands as the tenth overall leading cause of death in the United States. Suicide was the second leading...

read more
WHO Just Released ICD-11: 5 Notable Changes

WHO Just Released ICD-11: 5 Notable Changes

The World Health Organization has released the 11th edition of the International Classification of Diseases (ICD-11). Here are a few of the notable changes. ICD-11 is completely electronic with 40,600 more codes for injuries, diseases and cause of death than ICD-10....

read more
New CRC Screening Guidelines

New CRC Screening Guidelines

According to the new crc screening guidelines the American Cancer Society (ACS) released May 30, 2018 colorectal cancer screening should begin at 45 years old rather than 50. (4) Colorectal cancer (CRC) is the fourth most common cancer diagnosed among adults in the...

read more
First FDA approved CGRP Blocking Migraine Prevention Med

First FDA approved CGRP Blocking Migraine Prevention Med

The first migraine prevention medication was approved by the FDA in May, 2018. Pharmaceutical companies Amgen and Novartis designed the CGRP receptor blocking monthly injection Aimovig (erenumab-aooe) as a game changer for those who suffer from migraines. Aimovig is...

read more